Drug Profile
Research programme: GR Inflammation - Karo Pharma
Alternative Names: GR InflammationLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Karo Bio
- Class Glucocorticoids
- Mechanism of Action Glucocorticoid receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inflammation
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Inflammation in Sweden
- 02 Apr 2012 Early research in Inflammation in Sweden (unspecified route)